
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Pharmacol.
Sec. Cardiovascular and Smooth Muscle Pharmacology
Volume 16 - 2025 | doi: 10.3389/fphar.2025.1573332
This article is part of the Research Topic Vascular Dysfunction and Endocrine Disorders View all 7 articles
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Vitamin D plays is essential for calcium-phosphorus homeostasis, skeletal mineralization, and cardiovascular health. Its deficiency is associated with increased risk of metabolic syndrome and cardiovascular diseases. This study aimed to investigate the relationship between vitamin D deficiency and cardiovascular metabolic syndrome while identifying underlying mechanisms.: Forty-eight Wistar albino rats were divided into four groups: Control, Vitamin D Deficient (VD-), Metabolic Syndrome (MetS), and Combined Vitamin D Deficient with Metabolic Syndrome (VD-+ MetS). VD-and VD-+ MetS were fed a vitamin D deficient diet with increased calcium and phosphate to prevent secondary hyperparathyroidism and determine the direct effects of vitamin D. Metabolic syndrome was induced via 10% fructose in drinking water for 8 weeks. Evaluations included metabolic syndrome markers (hypertension, diabetes, dyslipidemia, and obesity), myocardial injury indicators (lactate dehydrogenase [LDH], creatine kinase-MB [CK-MB]), and oxidative stress/inflammation markers (malondialdehyde [MDA], nitric oxide [NO]). Vascular reactivity in thoracic aorta tissues, heart weight, and histopathological changes were also assessedThe results revealed that vitamin D deficiency was strongly related to each component of metabolic syndrome. Combined vitamin D deficiency and metabolic syndrome induced a highly significant increase in CK-MB, LDH, NO, and MDA levels (P < 0.05). However, there was no significant difference in CK-MB and NO levels for the (VD-) group compared to the control (P ˃ 0.05).Heart weight was significantly increased, and the histological examination of the heart showed increased left ventricular and Aortic wall thickness in the combined group (P < 0.05). Vascular response to phenylephrine was significantly increased while the vascular response to acetylcholine was significantly decreased significantly increased in all experimental groups (VD-, MetS, and VD-+ MetS) compared to control (P < 0.05).The present study demonstrates that vitamin D deficiency is considered one of the major risky and predisposing factors for cardiovascular metabolic syndrome, which could affect the outcome of the disease, partly by affecting endothelial function, vascular oxidative stress, and inflammation.
Keywords: Cardiovascular complications1, metabolic syndrome2, Oxidative Stress3, vascular function4, Vitamin D deficiency5
Received: 08 Feb 2025; Accepted: 03 Apr 2025.
Copyright: © 2025 Kamel, Mahjoub, Ahmad, Jamal, Bakhshwin, Burzangi, Shaker and Magadmi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Rania M Magadmi, Pharmacology Department, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.